Luliconazole with CAS 187164-19-8 is an topically active imidazole discovered by Nihon Nohyaku Co., Ltd. (Japan). The compound was successfully developed for topical antifungal.
Luliconazole (CAS 187164-19-8) is available in 1% cream and solution form for the treatment of dermatophytoses, candidiasis, pityriasis versicolor and other superficial infections.
Viwit Pharmaceuticals Limited (Viwit), founded in 2006, is a fast-growing research-based pharmaceutical healthcare company dedicated to the development, manufacture and marketing of innovative products in the fields of Finished Dosage Formulations, Active Pharmaceutical Ingredients and Fine Chemicals. Viwit manufactures all the products based on company’s core technologies, and is dedicated to serve customers for their greater success and healthier living.
Viwit consists of six subsidiaries, in...
View more >>
Basic Information
Business Type: Manufacturer
Product/Service (We Buy): 101 - 500 People
Year Established: 2006
Number of Employees: 101 - 500 People
Trade & Market
Main Markets: North America,Mid East,Western Europe
China
![CAS No:187164-19-8 (2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,<br />3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile](/structure/cas-187/187164-19-8.png)